Market Tracker

07/31 6:01pm ET

Keryx Biopharmaceuticals Inc (NASDAQ:KERX)

7.98
Delayed Data
As of Jul 31
 +0.23 / +2.97%
Today’s Change
7.29
Today|||52-Week Range
18.48
-43.60%
Year-to-Date

Today’s Trading

Previous close7.75
Today’s open7.78
Day’s range7.78 - 8.13
Volume1,591,666
Average volume (3 months)1,741,493
Market cap$826.7M
Dividend yield--
Data as of 3:59pm ET, 07/31/2015

Growth & Valuation

Earnings growth (last year)-112.07%
Earnings growth (this year)+23.04%
Earnings growth (next 5 years)+30.00%
Revenue growth (last year)+54.64%
P/E ratioNM
Price/Sales118.95
Price/Book10.06

Competitors

 Today’s
change
Today’s
% change
LXRXLexicon Pharmaceutic...-0.05-0.59%
NXTMNxStage Medical Inc+0.29+2.07%
AMRIAlbany Molecular Res...+0.06+0.28%
SGMOSangamo BioSciences ...+0.35+3.98%
Data as of 3:59pm ET, 07/31/2015

Financials

Next reporting dateAugust 5, 2015
EPS forecast (this quarter)-$0.26
Annual revenue (last year)$10.8M
Annual profit (last year)-$111.5M
Net profit margin-1,030.19%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Gregory P. Madison
Chief Financial Officer
Scott A. Holmes
Corporate headquarters
New York, New York

Forecasts